SunOpta Reports Strong 2025 Earnings Amidst Pending $6.50/Share Acquisition by Refresco

summarizeSummary

SunOpta reported strong financial results for fiscal year 2025, including a return to net earnings and significant revenue growth, providing a positive backdrop to its pending acquisition by Refresco for $6.50 per share.

check_boxKey Events

• Strong Fiscal Year 2025 Financial Performance

  SunOpta reported revenues of $817.7 million for 2025, a 13.0% increase from 2024. Gross profit rose 20.4% to $115.9 million, and operating income surged 154.6% to $39.7 million. The company achieved net earnings of $15.6 million ($0.13 diluted EPS) in 2025, a significant improvement from a net loss of $17.9 million in 2024.

• Pending Acquisition by Refresco for $6.50/Share

  The company reiterated its Arrangement Agreement with Refresco, announced on February 6, 2026, for an all-cash acquisition of $6.50 per share. The transaction is expected to close in the second quarter of 2026, after which SunOpta's common shares will be delisted from Nasdaq and the Toronto Stock Exchange. This news was previously disclosed in a PREM14A filing on February 27, 2026.

• Adjusted EBITDA Growth

  Adjusted EBITDA from continuing operations increased by 7.0% to $94.9 million in 2025, up from $88.7 million in 2024, reflecting improved operational efficiency and higher sales volumes.

• Share Repurchase Program Update

  SunOpta repurchased $1.0 million of common shares (163,227 shares at an average price of $6.04) during 2025 under a $25 million program authorized in May 2025. Approximately $24.0 million remains available under this program.

auto_awesomeAnalysis

SunOpta's annual report provides a comprehensive financial overview for fiscal year 2025, revealing a significant turnaround to profitability and robust growth across key metrics. This positive performance offers crucial context for the previously announced acquisition by Refresco for $6.50 per share. While the acquisition itself was disclosed earlier, these detailed audited financials confirm the company's strong operational health leading into the transaction, which is expected to close in Q2 2026. The report also highlights ongoing capital investments and a share repurchase program, indicating a company actively managing its capital structure and operations prior to the definitive acquisition.